Categories: HealthcareNews

Nihon Kohden Introduces First-Ever ATO-Certified Ventilators

IRVINE, Calif.–(BUSINESS WIRE)–#RespiratoryCare–Nihon Kohden, a global leader in medical technology, today announced the introduction of the industry’s first ventilators to receive Authority to Operate (ATO) certification under the Department of Defense’s (DoD) Risk Management Framework (RMF) eMASS #3389. This rigorous cybersecurity certification ensures Nihon Kohden’s ventilators meet the highest standards for data protection and operational security in healthcare settings.


“Our ATO-certified ventilators represent a new standard in medical device security,” said Roy Sakai, President of Nihon Kohden America. “This certification shows our commitment to protecting patient data and supporting healthcare providers in today’s digital world.”

Benefits of ATO-certified ventilators

  • Stronger patient data protection
  • Faster setup and installation
  • Lower risk of cyber attacks

Nihon Kohden’s commitment to maintaining this certification ensures its ventilators remain at the forefront of cybersecurity protection.

For more information about Nihon Kohden’s ATO-certified ventilators, please visit us.nihonkohden.com.

About Nihon Kohden

Founded in Japan in 1951, Nihon Kohden is a leading manufacturer, developer, and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe, Asia, and Latin America. The company’s products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed, and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low- invasive blood volume monitoring, and wireless patient monitoring.

Contacts

Beth Abbott

Senior Manager – Marketing Brand & Omnichannel

beth_abbott@nihonkohden.com

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

12 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

15 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

15 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

15 hours ago